Chembond Material Technologies Limited — Share Issue/Capital Change 2025

Nov 14, 2025

SE/CS/2025-26/72 November 14, 2025

To, To, Mumbai – 400 001 Mumbai – 400 051

BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (W), Scrip Code – 530871 Scrip Code – CHEMBOND

Ref: ISIN: INE995D01025

Sub: Intimation of In-principle Approval received for listing of up to a maximum of 400,000 Equity Shares of Rs. 5/- each to be issued under Chembond Material Technologies Limited - Employee Stock Option Plan 2025 ("CHEMBOND – ESOP 2025" / "Scheme").

Dear Sir / Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby informed you that BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) have issued In-principle approval letter vide Ref No. DSC/ESOP/IP/NB/3892/2025-26 and NSE/LIST/51202, dated November 13, 2025 and November 14, 2025 respectively, for the listing of up to a maximum of 400,0000 Equity Shares of Rs. 5/- each under CHEMBOND – ESOP 2025. Copies of the same have been enclosed herewith for your reference and record.

You are requested to kindly take the same on record.

Thanking You,

Yours faithfully,

For Chembond Material Technologies Limited

(formerly Chembond Chemicals Limited) Suchita Singh Suchita Hemantku mar Singh Digitally signed by Suchita Hemantkumar Singh Date: 2025.11.14 19:38:29 +05'30'

Company Secretary & Compliance Officer

Chembond Material Technologies Limited

(formerly Chembond Chemicals Limited) EL-71, Chembond Centre, Mahape MIDC, Navi Mumbai 400710. INDIA T: +91 22 62643000 - 03 ● F: +91 22 27681294 www.chembond.in CIN: L24100MH1975PLC018235

DCS/ESOP/IP/NB/3892/2025-26

November 13, 2025

To. The Company Secretary Chembond Material Technologies Limited EL-71, Chembond Centre, MIDC, Mahape, Navi Mumbai- 400710, Maharashtra,

Dear Sir/Madam,

Re: Application of In-principle approval for 4,00,000 Equity shares of Rs. 5/- each to be issued under "Chembond Material Technologies Limited - Employee Stock Option Plan 2025""

We acknowledge the receipt of your letter on the captioned matter regarding in-principle approval for issue and allotment of 4,00,000 Equity shares of Rs. 5/- each to be allotted by the Company, upon exercise of stock options in terms of Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, together with copy of statement under Reg 10(b) and other enclosures and subsequent submissions by the company. In this regard, the Exchange is pleased to grant in-principle approval for issue and allotment of a maximum of 4,00,000 Equity shares, which are likely to arise out of exercise of options as and when exercised under the Scheme subject to the company fulfilling the following conditions:

• 1. The company shall notify the Exchange as per the format prescribed under Reg 10(c) of Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 together with listing application after the shares were allotted and the same are credited to the beneficiaries account or share certificates have been dispatched, as may be applicable.
• 1. Payment of fees as may be prescribed from time to time.
• 1. Receipt of statutory and other approvals and compliance of quidelines issued by the statutory authorities including SEBI. RBI, and MCA etc.
• 1. Compliance to all quidelines/regulation/directions of the Exchange or any statutory authorities. documentary requirements from time to time.
• 1. Compliance of all conditions of Listing Agreement as on date of Listing.
• 1. Compliance to the Companies Act, 1956 / 2013 and other applicable laws.
• 1. Submissions of documents as given in the Checklist available on the BSE website under link http://www.bseindia.com/static/about/downloads.aspx?expandable=2

The Exchange reserves its right to withdraw its in-principle approval at any later stage if the information submitted to the Exchange is found to be incomplete/incorrect/misleading/false or for any contravention of Rules, Bye-laws and Regulations of the Exchange, Listing Agreement, Guidelines/Regulations issued by statutory authorities etc. Kindly note that the Exchange will issue trading permission from time to time upon receipt of notification under Reg. 10(c) and subject to the compliance of the conditions as stated above.

Yours faithfully,

Marian D'Souza Assistant Vice President

urghate Deputy Manager

Ref: NSE/LIST/51202 November 14, 2025

The Company Secretary Chembond Material Technologies Limited

Dear Sir/Madam,

Sub: In - Principle approval for listing upto a maximum of 4,00,000 equity shares of Rs. 5/- each of Chembond Material Technologies Limited to be allotted under CHEMBOND MATERIAL TECHNOLOGIES LIMITED EMPLOYEE STOCK OPTION PLAN 2025 (CHEMBOND - ESOP 2025 Scheme).

We are in receipt of your letter along with Statement under Regulation 10(b) as required under SEBI Regulations/Circulars and subsequent correspondences thereto, seeking in - principle approval for listing of a maximum of 4,00,000 equity shares of Rs. 5/- each to be allotted to the employees of the Company under the CHEMBOND MATERIAL TECHNOLOGIES LIMITED EMPLOYEE STOCK OPTION PLAN 2025 (CHEMBOND - ESOP 2025 Scheme) of the Company.

In this regard, the Exchange is pleased to grant in-principle approval for the above equity shares to be allotted on exercise of options as and when exercised subject to fulfilling the following listing conditions:

• 1. Notification to the Exchange as per Regulation 10 (c) together with listing application only after allotment of securities and credit to the beneficiaries account or dispatch of share certificates, as may be applicable.
• 1. Receipt of statutory and other approvals and compliance of guidelines issued by the statutory authorities including SEBI, RBI, MCA, etc.
• 1. Compliance with all the guidelines, regulations, directions of the Exchange or any statutory authorities, documentary requirements from time to time.
• 1. Compliance of all conditions of SEBI (LODR) Regulations, 2015 as on date of listing.
• 1. Compliance to the Companies Act, 1956, Companies Act, 2013 and other applicable laws.
• 1. Submissions of documents as given in the enclosed list (as per annexure).

The Exchange reserves its right to withdraw its in-principle approval at any later stage if the information submitted to the Exchange is found to be incomplete/incorrect/ misleading/false or in contravention of any Rules, Bye-laws and Regulations of the Exchange, Listing Regulations, Guidelines/ Regulations issued by statutory authorities, etc.

Kindly note that the Exchange will issue approval for listing and trading of equity shares subject to the compliances as stated above.

Kindly note, this Exchange letter should not be construed as approval under any other Act/Regulation/rule/bye laws (except as referred above) for which the Company may be required to obtain approval from other department(s) of the Exchange. The Company is requested to separately take up matter with the concerned departments for approval, if any.

Yours faithfully, For National Stock Exchange of India Limited

Ankita Gupta Manager

P.S. Checklist of all the further issues is available on website of the exchange at the following URL: https://www.nseindia.com/companies-listing/raising-capital-further-issues-main-sme-checklist

Annexure:

• 1. Certified true copy of statement under Regulation 10(c) as per the format prescribed in SEBI regulations/circulars.
• 1. NSDL/CDSL credit and/or dispatch of physical certificate confirmation by the R & T agent.
• 1. Certified true copy of Board resolution of allotment of shares.
• 1. List of allottees specifying the name of the allottee, number of shares allotted for the same.
• 1. Details of employees who have been granted options / shares in excess of 1% of share capital (in case of ESOPs) or 5% (in case of ESPS) of options / shares issued in one year.
• 1. Confirmation as to whether any Directors have been issued shares pursuant to ESOP/ESPS. If so, details of the issue to the Directors.